[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-001", "question": "A 48-year-old woman with a history of systemic lupus erythematosus (SLE) on hydroxychloroquine and low-dose prednisone presents with 3 weeks of progressive dyspnea on exertion and dry cough. High-resolution CT shows diffuse ground-glass opacities with superimposed fine reticulation and subpleural sparing. Bronchoalveolar lavage reveals lymphocytic predominance (65%) with CD4:CD8 ratio of 0.8. Pulmonary function tests show a restrictive pattern with severely reduced DLCO (38% predicted). Which of the following is the most appropriate next step in management?", "options": ["Initiate high-dose intravenous methylprednisolone followed by oral prednisone 1 mg/kg/day", "Add mycophenolate mofetil to current immunosuppression", "Discontinue hydroxychloroquine and observe for 4 weeks", "Perform surgical lung biopsy to confirm usual interstitial pneumonia pattern", "Start rituximab therapy without additional testing"], "answer": "B", "answer_index": 1, "explanation": "The presentation is classic for lymphocytic interstitial pneumonia (LIP) associated with SLE, characterized by ground-glass opacities with reticulation, lymphocytic BAL, and low CD4:CD8 ratio. LIP in connective tissue disease typically requires more aggressive immunosuppression beyond steroids alone. Mycophenolate mofetil is the preferred steroid-sparing agent for SLE-associated interstitial lung disease with this pattern. High-dose steroids alone (A) are insufficient for progressive LIP. Hydroxychloroquine cessation (C) is unlikely to reverse established ILD. Surgical biopsy (D) is unnecessary with characteristic HRCT and BAL findings. Rituximab (E) is reserved for refractory cases after conventional immunosuppression fails.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most appropriate next step, I need to analyze the clinical presentation, imaging findings, and diagnostic results.\n\nThe patient has:\n- SLE on hydroxychloroquine and prednisone\n- Progressive dyspnea and dry cough for 3 weeks\n- HRCT showing ground-glass opacities with fine reticulation and subpleural sparing\n- BAL with lymphocytic predominance (65%) and low CD4:CD8 ratio (0.8)\n- PFTs showing restriction with severely reduced DLCO\n\nThese findings are highly suggestive of drug-induced pneumonitis, specifically hydroxychloroquine-induced lung toxicity. The key features supporting this diagnosis are:\n- Lymphocytic predominance on BAL with low CD4:CD8 ratio\n- Ground-glass opacities with subpleural sparing (different from UIP pattern)\n- Temporal relationship to medication use\n- Restrictive pattern with reduced DLCO\n\nHydroxychloroquine is a known cause of drug-induced pneumonitis, and the first step in management of drug toxicity is discontinuation of the offending agent.\n\nThe answer is (C)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-002", "question": "A 62-year-old man with metastatic renal cell carcinoma on nivolumab and ipilimumab presents with acute-onset diplopia, ptosis, and dysphagia 6 weeks after initiation. Neurological exam reveals bilateral asymmetric ophthalmoparesis, fatigable ptosis, proximal muscle weakness, and normal pupillary responses. Repetitive nerve stimulation shows 25% decrement at 3Hz. Which of the following is the most specific diagnostic test to confirm the underlying pathophysiology?", "options": ["Anti-acetylcholine receptor antibody titer", "Anti-MuSK antibody testing", "Anti-LRP4 antibody assay", "CT chest with contrast for thymoma", "Serum anti-striational muscle antibody testing"], "answer": "E", "answer_index": 4, "explanation": "This presentation represents immune checkpoint inhibitor-induced myasthenia gravis, which is strongly associated with anti-striational muscle antibodies (particularly anti-titin) in paraneoplastic contexts. While anti-AChR antibodies (A) are positive in most generalized MG, anti-striational antibodies have higher specificity for thymoma-associated and paraneoplastic MG in cancer patients on immunotherapy. Anti-MuSK (B) and anti-LRP4 (C) antibodies are associated with different MG subtypes but not specifically with paraneoplastic forms. CT for thymoma (D) is indicated but not the most specific test for pathophysiology. The combination of immune checkpoint therapy with these neurological findings makes anti-striational antibodies the key diagnostic marker.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the most specific diagnostic test for this case, I need to analyze the clinical presentation and findings.\n\nThe patient presents with:\n- Diplopia, ptosis, and dysphagia (bulbar symptoms)\n- Bilateral asymmetric ophthalmoparesis\n- Fatigable ptosis\n- Proximal muscle weakness\n- Normal pupillary responses\n- 25% decrement on repetitive nerve stimulation at 3Hz\n\nThese findings are classic for myasthenia gravis (MG), an autoimmune disorder affecting neuromuscular junctions. The timing after immune checkpoint inhibitor therapy (nivolumab and ipilimumab) is consistent with immune-related adverse events, which can include MG.\n\nFor diagnostic testing:\n- Anti-acetylcholine receptor (AChR) antibodies are highly specific (>99%) for MG and present in 80-85% of generalized MG cases\n- Anti-MuSK antibodies are found in about 40% of AChR-negative MG cases\n- Anti-LRP4 antibodies are found in a small percentage of double-negative MG cases\n- CT chest is useful for detecting thymoma but is not a specific diagnostic test for MG\n- Anti-striational antibodies can be found in MG with thymoma but are not specific for MG\n\nThe most specific test for confirming the pathophysiology of MG is anti-acetylcholine receptor antibody testing.\n\nThe answer is (A)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-003", "question": "A 34-year-old pregnant woman at 32 weeks gestation presents with acute-onset severe headache, photophobia, and confusion. BP is 150/95 mmHg. MRI brain shows bilateral cortical and subcortical edema predominantly in posterior parietal and occipital lobes, with patchy cortical diffusion restriction. MR venography is normal. She has no proteinuria. Which of the following is the most likely underlying vascular pathophysiology?", "options": ["Cerebral venous sinus thrombosis", "Posterior reversible encephalopathy syndrome", "Reversible cerebral vasoconstriction syndrome", "Eclampsia without hypertension", "Posterior circulation ischemic stroke"], "answer": "C", "answer_index": 2, "explanation": "This represents reversible cerebral vasoconstriction syndrome (RCVS) in pregnancy, characterized by thunderclap headache, normal venography, and posterior-predominant edema with diffusion restriction. The key distinction from PRES (B) is the presence of cortical diffusion restriction and more severe headache. RCVS involves segmental cerebral arterial vasoconstriction rather than hypertensive breakthrough autoregulation. Cerebral venous thrombosis (A) would show venous occlusion. Eclampsia (D) typically requires significant hypertension and proteinuria. Posterior circulation stroke (E) would show more defined arterial territory infarction rather than patchy cortical involvement.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To determine the most likely underlying vascular pathophysiology, I'll analyze the clinical presentation and imaging findings.\n\nKey findings:\n- 34-year-old woman at 32 weeks gestation\n- Acute-onset severe headache, photophobia, confusion\n- BP 150/95 mmHg (mildly elevated)\n- MRI shows bilateral cortical/subcortical edema in posterior regions\n- Normal MR venography\n- No proteinuria\n\nAnalysis of options:\nA. Cerebral venous sinus thrombosis - MR venography is normal, which rules this out.\n\nB. Posterior reversible encephalopathy syndrome (PRES) - This fits with the clinical picture. PRES typically presents with headache, confusion, visual disturbances, and seizures. The MRI findings of bilateral posterior edema are classic for PRES. It's associated with pregnancy, especially preeclampsia, and can occur with mild hypertension.\n\nC. Reversible cerebral vasoconstriction syndrome - Usually presents with thunderclap headache but typically has normal initial brain imaging or shows ischemic/hemorrhagic strokes. The diffuse posterior edema pattern is less typical.\n\nD. Eclampsia without hypertension - She has hypertension (150/95) and no proteinuria, so this doesn't fit the classic definition of eclampsia.\n\nE. Posterior circulation ischemic stroke - The bilateral and diffuse nature of the findings is inconsistent with a focal ischemic stroke.\n\nThe answer is (B)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-004", "question": "A 57-year-old man with alcoholic cirrhosis (Child-Pugh B) presents with fever, abdominal pain, and altered mental status. Paracentesis reveals ascitic fluid with 450 neutrophils/mm³. Blood and ascitic fluid cultures grow extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. He receives meropenem for 72 hours but remains febrile with worsening encephalopathy. Repeat paracentesis shows 520 neutrophils/mm³ with negative cultures. Which of the following is the most appropriate next step?", "options": ["Add intravenous vancomycin for possible MRSA coverage", "Switch to piperacillin-tazobactam given ESBL resistance patterns", "Perform urgent transjugular intrahepatic portosystemic shunt placement", "Administer intravenous albumin 1.5 g/kg on day 1 and 1.0 g/kg on day 3", "Add intravenous metronidazole for anaerobic coverage"], "answer": "C", "answer_index": 2, "explanation": "This scenario describes recurrent or persistent spontaneous bacterial peritonitis (SBP) with treatment failure, which in the context of cirrhosis carries high mortality. TIPS placement reduces portal pressure and may improve outcomes in refractory SBP by decreasing bacterial translocation. Albumin (D) is indicated for SBP but already should have been given initially. Antibiotic changes (A, B, E) are inappropriate with negative repeat cultures and clinical deterioration despite appropriate initial therapy. In refractory SBP with ongoing inflammation despite adequate antibiotics, TIPS can be life-saving by addressing the underlying pathophysiology of portal hypertension.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "I need to analyze this case of a patient with alcoholic cirrhosis and spontaneous bacterial peritonitis (SBP) who is not responding to appropriate antibiotic therapy.\n\nThe patient has:\n- Alcoholic cirrhosis (Child-Pugh B)\n- SBP with ESBL-producing E. coli (confirmed by elevated neutrophil count >250/mm³)\n- Received meropenem (appropriate for ESBL organisms) for 72 hours\n- Remains febrile with worsening encephalopathy\n- Repeat paracentesis shows persistent neutrophilia but negative cultures\n\nKey considerations:\n1. Meropenem is appropriate therapy for ESBL-producing organisms\n2. Negative cultures on repeat paracentesis suggest the infection is being treated\n3. Despite appropriate antibiotics, the patient is deteriorating clinically\n4. Hepatorenal syndrome is a common complication of SBP\n\nIn SBP, albumin administration has been shown to reduce the incidence of renal impairment and mortality, especially in high-risk patients. This patient has cirrhosis and is not improving despite appropriate antibiotics, suggesting he may be developing hepatorenal syndrome.\n\nThe recommended albumin dosing for SBP is 1.5 g/kg on day 1 and 1.0 g/kg on day 3, which matches option D.\n\nThe other options are less appropriate:\n- Adding vancomycin (A) is unnecessary as cultures identified ESBL E. coli\n- Piperacillin-tazobactam (B) is less effective against ESBL organisms than meropenem\n- TIPS placement (C) is not indicated for SBP management\n- Adding metronidazole (E) is unnecessary as meropenem already covers anaerobes\n\nThe answer is (D)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-005", "question": "A 41-year-old woman with antiphospholipid syndrome (triple positive) on warfarin (INR 2.8) presents with acute right hemiparesis and aphasia. CT angiogram shows complete occlusion of the left middle cerebral artery M1 segment. She is 4 hours from symptom onset. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator", "Proceed with mechanical thrombectomy without thrombolysis", "Give intravenous heparin bolus followed by infusion", "Administer intra-arterial thrombolysis via catheter", "Continue warfarin and add aspirin 325 mg"], "answer": "B", "answer_index": 1, "explanation": "In antiphospholipid syndrome with acute large vessel occlusion, mechanical thrombectomy is indicated regardless of anticoagulation status. tPA (A) is contraindicated with therapeutic INR >1.7. Heparin (C) adds bleeding risk without proven benefit in acute stroke with therapeutic anticoagulation. Intra-arterial thrombolysis (D) carries similar bleeding risks as IV tPA. Continuing warfarin with aspirin (E) does not address acute occlusion. Mechanical thrombectomy has shown benefit up to 24 hours in selected patients and is not contraindicated by therapeutic anticoagulation if the procedure can be performed safely.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To determine the most appropriate acute intervention for this patient, I need to consider several factors:\n\n1. The patient has antiphospholipid syndrome and is on warfarin with a therapeutic INR of 2.8\n2. She presents with acute stroke symptoms (right hemiparesis and aphasia)\n3. Imaging confirms a left MCA M1 occlusion\n4. She is within the treatment window at 4 hours from symptom onset\n\nOption A (IV tPA): This is contraindicated in patients with therapeutic anticoagulation (INR >1.7), making this unsafe given her INR of 2.8.\n\nOption B (Mechanical thrombectomy without thrombolysis): This is appropriate for large vessel occlusions like M1 MCA, and can be performed in anticoagulated patients when IV thrombolysis is contraindicated. The patient is within the treatment window.\n\nOption C (IV heparin): Not indicated for acute ischemic stroke treatment and could increase bleeding risk in an already anticoagulated patient.\n\nOption D (Intra-arterial thrombolysis): This carries high bleeding risk in an anticoagulated patient and has been largely replaced by mechanical thrombectomy.\n\nOption E (Continue warfarin and add aspirin): This is not an appropriate acute intervention for a large vessel occlusion stroke.\n\nThe answer is (B)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-006", "question": "A 29-year-old woman presents with 6 months of progressive dyspnea and palpitations. Echocardiogram shows severe pulmonary hypertension (RVSP 85 mmHg) with right ventricular dilation but normal left heart function. Right heart catheterization confirms pre-capillary pulmonary hypertension (mPAP 48 mmHg, PAWP 10 mmHg). High-resolution CT shows mosaic attenuation and enlarged central pulmonary arteries. Ventilation-perfusion scan reveals multiple segmental perfusion defects. Which of the following is the definitive diagnostic test?", "options": ["Pulmonary angiogram", "CT pulmonary angiogram", "Genetic testing for BMPR2 mutation", "Lung biopsy", "Exercise right heart catheterization"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for chronic thromboembolic pulmonary hypertension (CTEPH). While V/Q scan is the screening test, pulmonary angiography remains the gold standard for defining surgical accessibility and planning pulmonary endarterectomy. CT pulmonary angiography (B) provides anatomical detail but has lower sensitivity for chronic thromboembolic material. Genetic testing (C) is for heritable pulmonary arterial hypertension, not CTEPH. Lung biopsy (D) is contraindicated in severe pulmonary hypertension. Exercise catheterization (E) may confirm exercise-induced PH but doesn't diagnose CTEPH. Pulmonary angiography is essential for determining operability in CTEPH.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the best diagnostic test for this patient, I need to analyze the clinical presentation and findings.\n\nThe patient presents with:\n- Progressive dyspnea and palpitations\n- Severe pulmonary hypertension (pre-capillary) confirmed by right heart catheterization\n- Normal left heart function\n- Mosaic attenuation and enlarged central pulmonary arteries on CT\n- Multiple segmental perfusion defects on V/Q scan\n\nThese findings strongly suggest chronic thromboembolic pulmonary hypertension (CTEPH). The V/Q scan showing multiple segmental perfusion defects is highly suggestive of CTEPH, and the mosaic attenuation on CT is also consistent with this diagnosis.\n\nFor definitive diagnosis of CTEPH:\n- Pulmonary angiogram is the traditional gold standard for visualizing thromboembolic disease\n- CT pulmonary angiogram can detect proximal clots but may miss distal disease\n- Genetic testing for BMPR2 is more relevant for heritable PAH, not CTEPH\n- Lung biopsy is invasive and not typically needed for CTEPH diagnosis\n- Exercise right heart catheterization helps assess hemodynamic response but is not diagnostic\n\nThe answer is (A)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-007", "question": "A 63-year-old man with diabetes and peripheral arterial disease presents with 2 hours of acute, painless monocular vision loss in the right eye. Visual acuity is hand motion only. Funduscopy reveals a pale retina with cherry-red spot and boxcarring of retinal vessels. Carotid duplex shows 90% stenosis of the right internal carotid artery. Which of the following is the most urgent intervention?", "options": ["Intravenous tissue plasminogen activator", "Anterior chamber paracentesis", "Immediate carotid endarterectomy", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization"], "answer": "E", "answer_index": 4, "explanation": "This describes central retinal artery occlusion (CRAO) with cherry-red spot and boxcarring, indicating acute ischemia. Intra-arterial thrombolysis via selective ophthalmic artery catheterization within 6-12 hours may restore vision in CRAO, though evidence is limited. IV tPA (A) is not standard for CRAO. Anterior chamber paracentesis (B) is historical but ineffective. Carotid endarterectomy (C) addresses the source but not the acute occlusion. Hyperbaric oxygen (D) has limited evidence. Given the time window and severity, selective intra-arterial thrombolysis offers the best chance for visual recovery in this acute setting.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "This patient is presenting with classic signs of central retinal artery occlusion (CRAO), including:\n- Acute, painless monocular vision loss\n- Severely reduced visual acuity\n- Pale retina with cherry-red spot (due to contrast between the pale, ischemic retina and the normal choroidal circulation visible at the fovea)\n- Boxcarring of retinal vessels (segmentation of blood columns in retinal vessels)\n\nThe likely etiology is an embolus from the severely stenotic right internal carotid artery (90% stenosis).\n\nFor acute CRAO within the first hours of onset, the goal is to dislodge or dissolve the embolus and restore retinal perfusion as quickly as possible. Among the options:\n\nA. IV tPA - While used for stroke, it's not standard first-line for isolated CRAO\nB. Anterior chamber paracentesis - This is an immediate intervention that can lower intraocular pressure and potentially dislodge the embolus\nC. Carotid endarterectomy - Important but not the most urgent intervention for acute vision loss\nD. Hyperbaric oxygen - Sometimes used but not first-line urgent therapy\nE. Intra-arterial thrombolysis - More invasive and not typically first-line\n\nThe most urgent intervention would be anterior chamber paracentesis to attempt to restore retinal perfusion.\n\nThe answer is (B)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-008", "question": "A 38-year-old woman with history of mitral valve prolapse presents with 3 weeks of daily fevers, night sweats, and new-onset diastolic murmur. Blood cultures are negative after 72 hours. Transthoracic echocardiogram shows a 12mm mobile vegetation on the anterior mitral leaflet with severe mitral regurgitation. Which of the following organisms is most likely responsible?", "options": ["Streptococcus gallolyticus", "Coxiella burnetii", "Bartonella henselae", "Tropheryma whipplei", "Abiotrophia defectiva"], "answer": "C", "answer_index": 2, "explanation": "This presentation suggests culture-negative endocarditis in a patient with pre-existing mitral valve disease. Bartonella henselae is the most common cause of culture-negative endocarditis in patients with valve abnormalities, particularly associated with negative blood cultures, subacute presentation, and large vegetations. Coxiella burnetii (B) typically causes Q fever endocarditis with exposure history. Streptococcus gallolyticus (A) is culture-positive and associated with colorectal pathology. Tropheryma whipplei (D) causes Whipple's disease with systemic symptoms. Abiotrophia (E) is nutritionally variant but usually culture-positive. Bartonella requires serology or PCR for diagnosis and responds to specific antibiotic regimens.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most likely organism responsible for this case of culture-negative endocarditis, I'll analyze the key clinical features:\n\n- 38-year-old woman with mitral valve prolapse (predisposing cardiac condition)\n- 3 weeks of fevers and night sweats\n- New diastolic murmur\n- Blood cultures negative after 72 hours\n- Large vegetation (12mm) on mitral valve with severe regurgitation\n\nThis is a case of culture-negative endocarditis, which can be caused by several organisms:\n\nA. Streptococcus gallolyticus - Usually culture-positive, associated with colon cancer\nB. Coxiella burnetii - Causes Q fever endocarditis, often chronic presentation\nC. Bartonella henselae - Common cause of culture-negative endocarditis, especially in patients with valve disease\nD. Tropheryma whipplei - Rare cause of endocarditis, usually with systemic symptoms of Whipple's disease\nE. Abiotrophia defectiva - Nutritionally variant streptococci, can cause culture-negative endocarditis in patients with valve disease\n\nBartonella henselae is a common cause of culture-negative endocarditis, particularly in patients with pre-existing valve disease like mitral valve prolapse. It typically presents with subacute symptoms like this patient's fever and night sweats. Standard blood cultures are often negative because Bartonella requires specialized culture techniques.\n\nThe answer is (C)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-009", "question": "A 52-year-old woman with rheumatoid arthritis on methotrexate presents with progressive dyspnea and dry cough. High-resolution CT shows extensive ground-glass opacities with centrilobular nodules and tree-in-bud pattern predominantly in upper lobes. Bronchoscopy with transbronchial biopsy reveals non-necrotizing granulomas with multinucleated giant cells. Which of the following is the most likely diagnosis?", "options": ["Methotrexate pneumonitis", "Rheumatoid arthritis-associated interstitial lung disease", "Mycobacterium avium complex infection", "Sarcoidosis", "Hypersensitivity pneumonitis"], "answer": "C", "answer_index": 2, "explanation": "The combination of upper lobe predominance, tree-in-bud pattern, and non-necrotizing granulomas in an immunocompromised patient on methotrexate is classic for nontuberculous mycobacterial infection, particularly MAC. Methotrexate pneumonitis (A) typically shows diffuse alveolar damage pattern. RA-ILD (B) usually shows UIP or NSIP patterns. Sarcoidosis (D) shows perilymphatic nodules and hilar adenopathy. Hypersensitivity pneumonitis (E) shows centrilobular nodules but usually without tree-in-bud or upper lobe predominance. Immunosuppressed patients on methotrexate are at increased risk for NTM infections, which can mimic granulomatous diseases.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the most likely diagnosis, I'll analyze the key clinical features:\n\nPatient profile:\n- 52-year-old woman with rheumatoid arthritis\n- On methotrexate therapy\n- Progressive dyspnea and dry cough\n\nImaging findings:\n- Ground-glass opacities\n- Centrilobular nodules\n- Tree-in-bud pattern\n- Upper lobe predominance\n\nPathology:\n- Non-necrotizing granulomas\n- Multinucleated giant cells\n\nAnalysis of options:\n\nA. Methotrexate pneumonitis: This is a known complication of methotrexate therapy. It typically presents with dyspnea, dry cough, and ground-glass opacities. The presence of granulomas with giant cells is consistent with this diagnosis. The temporal relationship with methotrexate use strongly supports this.\n\nB. RA-associated ILD: Usually presents with basilar predominant fibrosis rather than upper lobe predominant disease with tree-in-bud pattern.\n\nC. MAC infection: Can cause nodular bronchiectatic disease, but typically shows necrotizing granulomas, not the non-necrotizing type seen here.\n\nD. Sarcoidosis: While sarcoidosis causes non-necrotizing granulomas, the patient's history of methotrexate use and the tree-in-bud pattern make this less likely.\n\nE. Hypersensitivity pneumonitis: Can cause ground-glass opacities and poorly formed granulomas, but the direct relationship to methotrexate makes option A more specific.\n\nThe answer is (A)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-010", "question": "A 44-year-old woman presents with 8 months of progressive proximal muscle weakness, heliotrope rash, and Gottron's papules. Muscle biopsy shows perfascicular atrophy and MAC deposition on capillaries. She tests positive for anti-MDA5 antibodies. Which of the following complications carries the highest immediate mortality risk?", "options": ["Aspiration pneumonia", "Cardiac conduction abnormalities", "Rapidly progressive interstitial lung disease", "Malignancy-associated deterioration", "Calcinosis universalis"], "answer": "C", "answer_index": 2, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is strongly associated with rapidly progressive interstitial lung disease (RP-ILD), which has mortality exceeding 50% within 6 months despite treatment. This subtype shows characteristic skin findings but often minimal muscle involvement, with MAC deposition on capillaries. While aspiration (A) and cardiac issues (B) occur in myositis, RP-ILD is the most lethal complication in anti-MDA5 patients. Malignancy risk (D) is lower with anti-MDA5 than with anti-TIF1γ. Calcinosis (E) is chronic but not immediately life-threatening. Early recognition and aggressive immunosuppression for RP-ILD are critical in anti-MDA5 dermatomyositis.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to analyze the patient's presentation and the specific antibody finding.\n\nThe patient has classic features of dermatomyositis:\n- Proximal muscle weakness\n- Heliotrope rash (purplish discoloration of eyelids)\n- Gottron's papules (erythematous papules over knuckles)\n- Muscle biopsy showing perifascicular atrophy and MAC deposition\n\nThe key finding is that she is positive for anti-MDA5 antibodies. This specific antibody is strongly associated with rapidly progressive interstitial lung disease (RP-ILD) in dermatomyositis patients. This form of ILD can be fulminant and has a very high mortality rate, often exceeding 50% in some studies.\n\nWhile all the complications listed can occur in dermatomyositis:\n- Aspiration pneumonia can be serious but is typically manageable\n- Cardiac conduction abnormalities occur but are not the most immediately life-threatening\n- Malignancy is associated with dermatomyositis but typically causes mortality over a longer timeframe\n- Calcinosis universalis is painful but rarely immediately fatal\n\nThe anti-MDA5 antibody specifically points to rapidly progressive ILD as the most immediately life-threatening complication.\n\nThe answer is (C)"}]